Match!
Su Jong Yu
Seoul National University
203Publications
21H-index
1,573Citations
Publications 204
Newest
#1Hosim Soh (SNU: Seoul National University)H-Index: 3
#2Jaeyoung Chun (SNU: Seoul National University)H-Index: 8
Last.Jung-Hwan Yoon (SNU: Seoul National University)H-Index: 44
view all 13 authors...
Source
#1Jun Sik Yoon (Inje University)H-Index: 2
#2Byeong Geun Song (SMC: Samsung Medical Center)H-Index: 2
Last.Jung-Hwan Yoon (SNU: Seoul National University)H-Index: 44
view all 13 authors...
Several randomized controlled trials have shown that adjuvant immunotherapy with autologous cytokine-induced killer (CIK) cells prolongs recurrence-free survival (RFS) after curative treatment for hepatocellular carcinoma (HCC). We investigated the efficacy of adjuvant immunotherapy with activated CIK cells in real-world clinical practice. A total of 59 patients who had undergone curative surgical resection or radiofrequency ablation for stage I or II HCC, and subsequently received adjuvant CIK ...
Source
#1Yun Bin Lee (SNU: Seoul National University)H-Index: 8
#2Joon Yeul Nam (SNU: Seoul National University)H-Index: 4
Last.Jung-Hwan Yoon (SNU: Seoul National University)H-Index: 44
view all 14 authors...
Source
#1Jun Sik Yoon (Inje University)H-Index: 2
#2Dong Hyun Sinn (SKKU: Sungkyunkwan University)H-Index: 21
Last.Jung-Hwan YoonH-Index: 44
view all 16 authors...
Background: For patients with hepatocellular carcinoma (HCC), the definition of refractoriness to transarterial chemoembolization (TACE), which might make them a candidate for systemic therapy, is still controversial. We aimed to derive and validate a tumor marker-based algorithm to define the refractoriness to TACE in patients with intermediate-stage HCC. Methods: This multi-cohort study was comprised of patients who underwent TACE for treatment-naive intermediate-stage HCC. We derived a predic...
Source
#1Mi Young Jeon (Yonsei University)H-Index: 4
#2Beom Kyung Kim (Yonsei University)H-Index: 26
Last.Seung U. Kim (Yonsei University)H-Index: 78
view all 12 authors...
Source
#1Jun Sik Yoon (SNU: Seoul National University)H-Index: 2
#2Su Jong Yu (SNU: Seoul National University)H-Index: 21
Last.Jung-Hwan Yoon (SNU: Seoul National University)H-Index: 44
view all 7 authors...
Source
#1Young Youn Cho (SNU: Seoul National University)H-Index: 9
#2Young Hwan Choi (CAU: Chung-Ang University)H-Index: 3
Last.Jung-Hwan Yoon (SNU: Seoul National University)H-Index: 44
view all 7 authors...
Source
#1Jeong-Ju Yoo (SCH: Soonchunhyang University)H-Index: 6
#2Su Jong Yu (SNU: Seoul National University)H-Index: 21
Last.Jung-Hwan Yoon (SNU: Seoul National University)H-Index: 44
view all 9 authors...
Source
#1S.-W. Kim (SNU: Seoul National University)H-Index: 16
#2Myung-Shin Kim (SNU: Seoul National University)H-Index: 4
Last.Yeon Kyung Kim (SNU: Seoul National University)H-Index: 21
view all 12 authors...
Background Abdominal wall hernias are common in patients with ascites. Elective surgical repair is recommended for the treatment of abdominal wall hernias. However, surgical hernia repair in cirrhotic patients with refractory ascites is controversial. In this study, we aimed to evaluate the outcomes of elective surgical hernia repair in patients with liver cirrhosis with and without refractory ascites.
Source
#1Young Jun ChangH-Index: 21
#2Yuri ChoH-Index: 14
Last.Kyung-Suk SuhH-Index: 38
view all 17 authors...
Background and Aims: Several models have been developed to predict tumor the recurrence of hepatocellular carcinoma (HCC) after liver transplantation besides the conventional Milan criteria (MC), including the MoRAL score. This study aimed to compare the prognostication power of the MoRAL score to most models designed so far in the Eastern and Western countries. Methods: This study included 564 patients who underwent living donor liver transplantation (LDLT) in three large-volume hospitals in Ko...
Source
12345678910